Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karan Mediratta"'
Autor:
Karan Mediratta, Sara El-Sahli, Marie Marotel, Muhammad Z. Awan, Melanie Kirkby, Ammar Salkini, Reem Kurdieh, Salman Abdisalam, Amit Shrestha, Chiara Di Censo, Andrew Sulaiman, Sarah McGarry, Jessie R. Lavoie, Zhen Liu, Seung-Hwan Lee, Xuguang Li, Giuseppe Sciumè, Vanessa M. D’Costa, Michele Ardolino, Lisheng Wang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChemotherapy remains the mainstay treatment for triple-negative breast cancer (TNBC) due to the lack of specific targets. Given a modest response of immune checkpoint inhibitors in TNBC patients, improving immunotherapy is an urgent and c
Externí odkaz:
https://doaj.org/article/10213cd0c20d41adb4e2783bba54bf80
Autor:
Frederic St‐Denis‐Bissonnette, Sarah E. Cummings, Shirley Qiu, Andrew Stalker, Gauri Muradia, Jelica Mehic, Karan Mediratta, Shelby Kaczmarek, Dylan Burger, Seung‐Hwan Lee, Lisheng Wang, Jessie R. Lavoie
Publikováno v:
Journal of Extracellular Vesicles, Vol 12, Iss 12, Pp n/a-n/a (2023)
Abstract Natural killer cell‐derived extracellular vesicles (NK‐EVs) have shown promising potential as biotherapeutics for cancer due to their unique attributes as cytotoxic nanovesicles against cancer cells and immune‐modulatory activity towar
Externí odkaz:
https://doaj.org/article/1906ed4190454e6db53b02b8e2e4579a
Autor:
Frederic St-Denis-Bissonnette, Rachil Khoury, Karan Mediratta, Sara El-Sahli, Lisheng Wang, Jessie R. Lavoie
Publikováno v:
Cancers, Vol 14, Iss 451, p 451 (2022)
Cancers
Cancers
Simple Summary Triple-negative breast cancer (TNBC) is the deadliest subtype of breast cancer, with limited treatment options. This review summarizes the most recent applications of extracellular vesicles (EVs) in TNBC as diagnostic/prognostic biomar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290859e48cf2900a609db5869b099405
https://www.mdpi.com/2072-6694/14/2/451
https://www.mdpi.com/2072-6694/14/2/451
Publikováno v:
Cancers, Vol 12, Iss 3529, p 3529 (2020)
Cancers
Cancers
Simple Summary The breakthrough of immunotherapy in melanoma has generated a glimmer of hope for lethal triple negative breast cancer (TNBC). This review summarizes the recent advances, challenges and potential new approaches of immunotherapy in TNBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3102927624f0b45a69e6873f3ef734f
https://www.mdpi.com/2072-6694/12/12/3529
https://www.mdpi.com/2072-6694/12/12/3529
Autor:
Lisheng Wang, Karan Mediratta, Jason Chambers, Emil Al-Kadi, Alexandra Phan, Xuguang Li, Jim Dimitroulakos, Andrew Sulaiman, Christina L. Addison, Li Li, Sarah McGarry
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5788, p 5788 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 16
International Journal of Molecular Sciences
Volume 21
Issue 16
Development of targeted therapies for triple-negative breast cancer (TNBC) is an unmet medical need. Cisplatin has demonstrated its promising potential for the treatment of TNBC in clinical trials
however, cisplatin treatment is associated with
however, cisplatin treatment is associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1d2f0c963fcf6ba9aa7c9efa5b3451
https://www.mdpi.com/1422-0067/21/16/5788
https://www.mdpi.com/1422-0067/21/16/5788